|
學名
|
Hepatitis B immune globulin
|
|
商品名
|
HyperHep B S/DHepatect CP (HBIG IV)HyperHep B S/D
|
|
中文名
|
(公費)B型肝炎免疫人血球蛋白注射液立保B型肝炎抗體注射液B型肝炎免疫人血球蛋白注射液
|
|
規格含量
|
0.5ml/syringe500IU/10ml/vial5ml/vial
|
藥理分類 |
05. BIOLOGIC AND IMMUNOLOGIC AGENTS; ; |
05.04. IMMUNE GLOBULINS;; |
|
藥理作用 |
Provide prophylactic passive immunity to hepatitis B infection to those individuals exposed, newborns of mothers known to be hepatitis B surface antigen positive, hepatitis B immune globulin is not indicated for treatment of active hepatitis B infections and is ineffective in the treatment of chronic active hepatitis B infection |
適應症(藥袋) |
預防B型肝炎感染 |
懷孕分級 |
C 動物試驗顯示有致畸胎的結果，但沒有針對孕婦或動物有對照組的研究可證明其危險性。
|
授乳安全性 |
Unknown |
用法用量 |
HyperHep B S/D
IM
Postexposure prophylaxis of neonates born to HBsAg-positive
0.5ml IM within 12 hrs after birth
Hepatitis prophylaxis, postexposure
0.06 ml/kg IM within 24 hrs of percutaneous or permucosal exposure and within
14 days of sexual exposure
Hepatect CP
IVD
In the anhepatic phase: 10,000 IU (200 ml)
On OP days 1-7: 2,000 IU (40 ml)/day.
Max:1 ml/kg/hr.
|
副作用 |
Erythema at injection site, pain at injection site, headache, myalgias, malaise, nausea, vomiting, joint stiffness |
禁忌 |
Allergies to gamma globulin or anti-immunoglobulin antibiotics; allergies to thimerosal, IgA deficiency |
注意事項 |
請冰箱保存。 |
藥品與食物交互作用 |
|
|
|
建立者 |
100224 |
建立時間 |
|
維護者 |
103617 |
維護時間 |
2013-12-05 07:57:35 |
|